Stock Report

All about this stock under one free report Last Updated: 30-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Repligen (RGEN) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$176.27

up-down-arrow $-5.76 (-3.16%)

As on 28-Aug-2026 16:00EDT

Market cap

info icon

$9,948 Mln

Revenue (TTM)

info icon

$785 Mln

P/E Ratio

info icon

251.8

P/B Ratio

info icon

4.9

Div. Yield

info icon

0 %

Edit peer-selector-edit
Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Market cap ($ Mln)
 9,948 12,753 10,906 9,762 9,638
Revenue ($ Mln)
 785 1,505 613 2,589 6,561
Net Profit ($ Mln)
 41.54 160.59 -188.05 222.40 -578.00
Net Margin (%)
 5.29 10.67 -30.68 8.59 -8.81
RoE (%)
 1.97 10.86 -28.10 3.04 -10.33
Price to Earnings
 251.81 79.35 -- 44.47 --
Price-To-Book
 4.86 8.41 16.38 1.26 1.68

Income Statement ($ Mln)

Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Operating Revenue arrow
785.10 1,504.87 612.84 2,589.30 6,561.10
Cost of Revenue arrow
384.30 483.98 127.96 1,245.50 4,473.00
Gross Profit arrow
347.62 942.44 393.22 1,343.60 2,139.40
Operating Expenses arrow
335.50 833.56 565.37 1,108.90 2,373.70
Operating Profit (EBIT) arrow
65.30 187.34 -80.49 235.00 -285.60
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
52.15 203.83 -192.83 350.40 -472.00
Provision for Tax arrow
10.61 43.24 -4.79 128.00 106.00
Profit after Tax (Net Income) arrow
41.54 160.59 -188.05 222.40 -578.00
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 93.19 0.00 0.00 0.00

Liabilities ($ Mln)

Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Shareholder's Funds arrow
2,112.03 1,530.77 682.49 7,173.90 5,630.20
Minority Interest arrow
0.00 0.00 0.00 0.00 0.00
Non-Current Liabilities arrow
705.49 210.18 135.71 2,116.80 4,583.70
Current Liabilities arrow
132.66 233.78 102.33 961.30 1,382.00
Total Liabilities arrow
2,949.70 1,826.52 893.49 10,576.50 11,794.70

Assets ($ Mln)

Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Non-Current Assets arrow
1,749.63 630.60 404.74 7,231.50 9,133.70
Current Assets arrow
1,200.55 1,344.12 515.78 3,020.50 2,462.20
Total Assets arrow
2,949.70 1,826.52 893.49 10,576.50 11,794.70
Total Debt* arrow
690.94 212.71 102.84 1,203.70 3,697.80
Net Current Assets arrow
1,067.90 1,110.35 413.45 2,059.20 1,080.20

Cashflow ($ Mln)

Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Cash From Operating Activities arrow
117.42 238.66 -46.34 532.20 623.80
Cash Flow from Investing Activities arrow
-298.47 -404.59 -77.61 -189.70 -130.50
Cash from Financing Activities arrow
-15.21 26.53 11.89 -283.20 -409.40
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
ROCE (%) arrow
1.79 11.76 -22.53 8.98 -5.43
ROE (%) arrow
1.97 10.86 -28.10 3.04 -10.33
ROA (%) arrow
1.36 7.95 -18.00 2.02 -4.08
EBIT Margin (%) arrow
9.87 13.63 -30.58 -5.99 -4.47
Net Margin (%) arrow
5.29 10.67 -30.68 8.59 -8.81
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Revenue Growth (%) arrow
16.49 17.55 41.55 1.37 -1.57
EBIT Growth (%) arrow
920.91 17.49 -116.42 -131.06 -129.16
Net Profit Growth (%) arrow
400.42 8.72 -102.66 -30.32 -184.08
EPS Growth (%) arrow
394.30 8.12 -96.88 -29.66 -184.11
Book Value Growth (%) arrow
2.16 17.33 -12.65 2.19 -9.82

Valuation Ratios

 Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Price / Earnings arrow
189.42 68.93 -34.59 -- -14.68
Price / Book Value arrow
4.86 8.58 9.90 -- 1.40
Dividend Yield (%) arrow
0.00 -- -- -- --
EV/EBITDA arrow
81.02 53.25 -43.50 -- 81.94
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Debt to Equity arrow
0.26 0.00 0.00 0.11 0.65
Short term debt to equity ratio arrow
0.01 0.01 0.00 0.06 0.01
Current Ratio arrow
9.05 5.75 5.04 3.14 1.78
Quick Ratio arrow
7.64 3.86 4.46 2.33 1.18
Interest Coverage arrow
3.36 157.91 -38.31 8.18 -1.64

Operating Efficiency Ratios

 Repligen (RGEN) Penumbra (PEN) Glaukos Corp (GKOS) Bio-Rad Laboratories Avantor (AVTR)
Debtors to sales (%) arrow
20.09 12.65 22.67 17.06 17.36
Asset Turnover arrow
0.26 0.74 0.59 0.24 0.46
Receivable days arrow
72.41 46.54 60.95 65.39 58.79
Inventory Days arrow
146.53 331.92 193.84 221.09 64.13
Payable days arrow
29.05 26.16 60.19 37.02 58.13
Cash Conversion Cycle arrow
189.88 352.30 194.60 249.46 64.79
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...